Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill

NCT04958512 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cerebrovascular Diseases

Interventions

DRUG: Yangxue Qingnao pill
DRUG: Hydergotoxine mesylate tablets
OTHER: blank control group

Sponsor

Peking University Third Hospital

Collaborators

[object Object]